Skip to main content

Table 1 Baseline characteristics of ART initiators at Queen Elizabeth Central Hospital between 2004 and 2011

From: Evidence of improving antiretroviral therapy treatment delays: an analysis of eight years of programmatic outcomes in Blantyre, Malawi

Variable Female % Male % P-value
Total 8,988   6,961   
Median age at initiation (years); IQR 31 25-38 34 27-42 <0.001
Age group at initiation      
  0-5 years 475 5.3 537 7.8 <0.001
  5-15 years 583 6.5 521 7.5  
  15-25 years 1,042 11.7 335 4.9  
  25-35 years 3,715 41.6 2,033 29.4  
  35-45 years 2,077 23.3 2,091 30.3  
  ≥ 45 years 1,040 11.6 1,387 20.1  
Site of HIV test      
  QECH 3,023 33.6 2,361 33.9 0.860
  Outside QECH 4,140 46.1 3,176 45.6  
  Unknown 1,825 20.3 1,424 20.5  
WHO stage at initiation      
  Stage 1 or 2 3,264 36.3 2,094 30.1 <0.001
  Stage 3 or 4 5,724 63.7 4,867 69.9  
CD4 count (cells/μl)*      
  ≥ 350 167 3.8 103 3.1 <0.001
  250 – 350 1,013 22.9 755 22.7  
  50 – 250 2,719 61.4 1,930 58.1  
  <50 528 11.9 533 16.1  
Year of ART initiation      
  2004-2005 562 6.3 404 5.8 <0.001
  2005-2006 1,208 13.4 801 11.5  
  2006-2007 1,250 13.9 887 12.7  
  2007-2008 1,253 13.9 1,010 14.5  
  2008-2009 1,249 13.9 964 13.9  
  2009-2010 1,134 12.6 1,024 14.7  
  2010-2011 1,154 12.8 1,002 14.4  
  2011-2012 1,178 13.1 866 12.4  
Median time (days) between last positive HIV test and initiation of ART; IQR 36 14-120 33 12-94 0.001
  1. *CD4 count measured in 4,427 women and 3,321 men. Denominator for this variable is number of men and women who had CD4 count measured.